ATAI Life Sciences N.V [ATAI] stock is trading at $1.58, up 4.64%. An important factor to consider is whether the stock is rising or falling in short-term value. The ATAI shares have gain 13.67% over the last week, with a monthly amount glided 32.77%, and seem to be holding up well over a long-time horizon.
From an analyst’s perspective:
ATAI Life Sciences N.V [NASDAQ: ATAI] stock has seen the most recent analyst activity on November 18, 2024, when H.C. Wainwright reiterated its Buy rating and also revised its price target to $10 from $15. Previously, Maxim Group upgraded its rating to Buy on April 03, 2024, and kept the price target unchanged to $6. On November 01, 2022, Loop Capital initiated with a Buy rating and assigned a price target of $18 on the stock. Maxim Group started tracking the stock assigning a Buy rating and suggested a price target of $25 on November 30, 2021. ROTH Capital initiated its recommendation with a Buy and recommended $32 as its price target on November 11, 2021. H.C. Wainwright started tracking with a Buy rating for this stock on October 18, 2021, and assigned it a price target of $40. In a note dated September 01, 2021, Jefferies initiated an Buy rating and provided a target price of $27 on this stock.
ATAI Life Sciences N.V [ATAI] stock has fluctuated between $1.03 and $2.85 over the past year. Currently, Wall Street analysts expect the stock to reach $6 within the next 12 months. ATAI Life Sciences N.V [NASDAQ: ATAI] shares were valued at $1.58 at the most recent close of the market. An investor can expect a potential return of 279.75% based on the average ATAI price forecast.
Analyzing the ATAI fundamentals
ATAI Life Sciences N.V [NASDAQ:ATAI] reported sales of 0.33M for the trailing twelve months, which represents a drop of -54.02%. Gross Profit Margin for this corporation currently stands at 0.2% with Operating Profit Margin at -319.87%, Pretax Profit Margin comes in at -386.15%, and Net Profit Margin reading is -388.53%. To continue investigating profitability, this company’s Return on Assets is posted at -0.65, Equity is -0.66 and Total Capital is -0.6. Upon thorough examination of the company’s fundamental financial framework, it becomes apparent that the debt-to-equity ratio stands at 0.16.
Before buying any particular stock, readers tend to pay close attention to the indicators that support and create resistance. The company’s stock is currently sitting at 1.4950 points at the first support level, and at 1.4100 for the second support level. However, for the 1st resistance point, the stock is sitting at 1.6500, and for the 2nd resistance point, it is at 1.7200.
Ratios To Look Out For
For context, ATAI Life Sciences N.V’s Current Ratio is 5.81. On the other hand, the Quick Ratio is 5.81, and the Cash Ratio is 1.53. Considering the valuation of this stock, the price to sales ratio is 803.42, the price to book ratio is 1.82.
Transactions by insiders
Recent insider trading involved ATAI Life Sciences N.V., 10% Owner, that happened on Sep 26 ’24 when 2.66 million shares were sold., Brand Florian completed a deal on May 16 ’24 to sell 0.15 million shares. Meanwhile, Chief Financial Officer Johnson Anne Nagengast sold 27410.0 shares on Apr 02 ’24.
